HALEON UK HOLDING NEW ZEALAND LIMITED

Company number 12342879

Date	Type	Description	View / Download
24 May 2022	CS01	Confirmation statement made on 24 May 2022 with no updates	(3 pages)
06 Apr 2022	TM01	Termination of appointment of Edinburgh Pharmaceutical Industries Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	TM01	Termination of appointment of Glaxo Group Limited as a director on 6 April 2022	(1 page)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.4 Limited as a director on 6 April 2022	(2 pages)
06 Apr 2022	AP02	Appointment of Gsk Consumer Healthcare Holdings No.8 Limited as a director on 6 April 2022	(2 pages)
09 Mar 2022	TM01	Termination of appointment of David John Cottam as a director on 4 March 2022	(1 page)
09 Mar 2022	AP01	Appointment of Mr Lee Di Pietro as a director on 4 March 2022	(2 pages)
14 Dec 2021	CS01	Confirmation statement made on 1 December 2021 with updates	(4 pages)
09 Dec 2021	AA	Audit exemption subsidiary accounts made up to 31 December 2020	(18 pages)
02 Dec 2021	SH19	Statement of capital on 2 December 2021 GBP 3	(3 pages)
02 Dec 2021	SH20	Statement by Directors	(1 page)
02 Dec 2021	CAP-SS	Solvency Statement dated 01/12/21	(1 page)
02 Dec 2021	RESOLUTIONS	Resolutions RES13 ‐ Reduce share prem a/c 01/12/2021	(2 pages)
17 Jun 2021	SH02	Sub-division of shares on 28 May 2021	(6 pages)
10 Jun 2021	PSC02	Notification of Gsk Consumer Healthcare Holdings (No.1) Limited as a person with significant control on 28 May 2021	(2 pages)
10 Jun 2021	PSC07	Cessation of Prism Pch Limited as a person with significant control on 28 May 2021	(1 page)
10 Jun 2021	PSC02	Notification of Prism Pch Limited as a person with significant control on 28 May 2021	(2 pages)
10 Jun 2021	PSC07	Cessation of Glaxosmithkline Consumer Healthcare (Overseas) Limited as a person with significant control on 28 May 2021	(1 page)
24 May 2021	PARENT_ACC	Consolidated accounts of parent company for subsidiary company period ending 31/12/20	(304 pages)
24 May 2021	AGREEMENT2	Notice of agreement to exemption from audit of accounts for period ending 31/12/20	(1 page)
24 May 2021	GUARANTEE2	Audit exemption statement of guarantee by parent company for period ending 31/12/20	(3 pages)
23 Dec 2020	CS01	Confirmation statement made on 1 December 2020 with updates	(4 pages)
17 Aug 2020	AP01	Appointment of Mr Thomas Ian Whittle as a director on 31 July 2020	(2 pages)
13 Aug 2020	TM01	Termination of appointment of Antrinkos Andrew Aristidou as a director on 31 July 2020	(1 page)
18 Mar 2020	AP01	Appointment of Mr. David John Cottam as a director on 10 March 2020	(2 pages)